RA Capital Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-1,250,000
| Closed | -$18.8M | – | 29 |
|
|
2017
Q3 | $18.8M | Hold |
1,250,000
| – | – | 1.69% | 18 |
|
|
2017
Q2 | $11M | Buy |
+1,250,000
| New | +$11M | 1.26% | 18 |
|
|
2016
Q4 | – | Sell |
-899,438
| Closed | -$4.16M | – | 32 |
|
|
2016
Q3 | $4.16M | Sell |
899,438
-266,500
| -23% | -$1.23M | 0.43% | 27 |
|
|
2016
Q2 | $6.75M | Sell |
1,165,938
-1,046,098
| -47% | -$6.06M | 0.93% | 21 |
|
|
2016
Q1 | $13.4M | Hold |
2,212,036
| – | – | 1.71% | 17 |
|
|
2015
Q4 | $20.2M | Buy |
2,212,036
+766,606
| +53% | +$7M | 2% | 18 |
|
|
2015
Q3 | $8.15M | Buy |
1,445,430
+225,221
| +18% | +$1.27M | 1.17% | 27 |
|
|
2015
Q2 | $13.5M | Hold |
1,220,209
| – | – | 1.36% | 23 |
|
|
2015
Q1 | $19.1M | Hold |
1,220,209
| – | – | 1.9% | 15 |
|
|
2014
Q4 | $18.6M | Hold |
1,220,209
| – | – | 1.99% | 14 |
|
|
2014
Q3 | $13.2M | Sell |
1,220,209
-1,571,096
| -56% | -$16.9M | 1.56% | 17 |
|
|
2014
Q2 | $42.6M | Sell |
2,791,305
-2,430,748
| -47% | -$37.1M | 4.31% | 6 |
|
|
2014
Q1 | $94.4M | Sell |
5,222,053
-5,219
| -0.1% | -$94.4K | 6.77% | 1 |
|
|
2013
Q4 | $72.6M | Buy |
5,227,272
+969,028
| +23% | +$13.5M | 8.46% | 2 |
|
|
2013
Q3 | $44.7M | Sell |
4,258,244
-1,109,850
| -21% | -$11.6M | 4.66% | 6 |
|
|
2013
Q2 | $41.9M | Buy |
+5,368,094
| New | +$41.9M | 5.56% | 4 |
|